Roche Diagnostics Moves Up On Training Magazine’s 2005 Top 100 List To No. 15

Roche Diagnostics Corporation of Indianapolis, Ind., the number one diagnostics company globally, today announced that it has been named to Training magazine’s 2005 Top 100 list for the third year. This year, Roche Diagnostics moved up in the ranking to 15, from 21 in 2005 and 24 in 2004.

Training magazine recognizes organizations that stand head and shoulders above their peers in workforce training and development. The organizations they select not only make sizable investments in developing their people, they do so strategically and creatively. In addition, among the top companies, training is focused on driving targeted business results and their ability to measure the impact on their business.

“We are certainly pleased that we have moved up every year, since we first applied to Training magazine’s Top 100 List, and that we are leading the way, along with other top U.S. companies. It is important to emphasize however, our motivation to excel in training is the development of our people. The skills of our people and their performance are what will make our business excel,” said John Getty, Vice President Learning and Development at Roche Diagnostics. “One of our business focuses is to be a place where people want to work. Part of that is giving our people the appropriate tools and training to develop their skills, in order to be successful in their jobs and their careers,” he added.

Over the last several years, Roche Diagnostics has invested in training and development programs for its approximately 3,500 people who are located in Indianapolis and other locations across the U.S. In 2001, Roche Diagnostics implemented a comprehensive development approach that entails each employee having an Individual Development Plan focused on short- and long-term goals. In addition, in 2003, Roche launched a new learning system, titled “myLEARNINGlink” to broaden the scope and increase the efficiency and effectiveness of its training and development opportunities. This recognition reinforces Roche’s outstanding work in continuing market leadership through leveraging innovative training and development as a foundation of its business strategy.

The ranking for the Training Top 100 is based on factors such as:
     • Financial investment in employee development,
     • Type and scope of training and development programs provided
     • Quality of programs, and
     • How closely development efforts are linked to business goals and objectives.
     • For more information, please visit www.trainingmag.com

About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-intensive healthcare groups. Its core businesses are pharmaceuticals and diagnostics. As a supplier of innovative products and services for the prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in Diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology. In 2004, the Pharmaceuticals Division generated 21.7 billion Swiss francs in prescription drug sales, while the Diagnostics Division posted sales of 7.8 billion Swiss francs. Roche employs roughly 65,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai.

Roche’s Diagnostics Division, with a uniquely broad product portfolio, supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide.

Roche Diagnostics’ North American headquarters is located in Indianapolis, Ind. (www.roche-diagnostics.us) For further information, please visit our websites www.roche.us and www.roche-diagnostics.com

For more information please contact: